The Santis team shares its insights on the key sectors and factors driving decisions and change in the health care and life sciences sector across Canada.

SUMMARY: Ontario Cabinet Shuffle (2017)

Today, Premier Kathleen Wynne unveiled a small cabinet shuffle to fill the vacancy left by the departure of former community  safety and corrections Minister David Orazietti.

Read More

SUMMARY: CIHI’s Report on Public Drug Spending

Before the holidays, CIHI released its annual analysis of public drug spending, and it’s worth more than a cursory examination for anyone who cares about how much money is spent on pharmaceuticals in Canada, on what and where, and how those numbers have changed over time.

Read More

SUMMARY: Highlights from the Health and Long-Term Care Mandate Letter 2016

Released this morning, the September 2016 Mandate Letter to the Minister of Health and Long-Term Care outlines the upcoming priorities of the Ministry.

Read More

SUMMARY: Ontario doctors vote to reject the tentative agreement with ON govt

Members of the OMA voted on Sunday, August 15 to reject the tentative Physician Services Agreement with the Ontario government, first announced July 11.

Read More

INSIGHTS: Ontario doctors can be at the table, or on the menu

Santis Principal Patrick Nelson writes: "A past president of the Ontario Medical Association (OMA) used an expression regularly when talking to doctors about the need to partner with government to design a better health care system."

Read More

SUMMARY: Ontario Cabinet Shuffle (2016)

Today, Premier Kathleen Wynne unveiled her mid-term cabinet shuffle.

Read More

SUMMARY: Connecting the Dots for Patients

Health Quality Ontario released a report June 1 examining the results of the Commonwealth Fund International Health Policy Survey of Primary Care Doctors in the Ontario context.

Read More

SUMMARY: Turing Pharma’s Stunning Price Hike Casts Shadow on Entire Industry

In mid-September Martin Shkreli, CEO of little-known Turing Pharmaceuticals, attracted international attention for a stunning decision to hike the price of one of the company’s flagship products.

Read More